Introduction to RNA therapeutics

Develop your RNA technology skills on this course brought to you by our RNA Training Academy.

What will you learn?

You'll discover how RNA/ lipid nanoparticle (LNP) therapeutics are made, unravel the RNA therapeutics we've helped to produce, and gain insight to the future of these technologies.

How a cell works
How to make RNA/LNP therapeutics
How RNA therapeutics work
The end-to-end RNA manufacturing process
An introduction to the analytical methods required for RNA/LNP
The future of RNA/LNP technology

How is the course structured?

'Introduction to RNA therapeutics' is an instructor-led, CPD-accredited course delivered in an engaging way by our incredible RNA experts with videos and animation. If you choose to attend our interactive course, there's also the opportunity to ask any burning questions in a dedicated Q&A session.

Is this course right for you?

Yes! If you're...

Working in RNA or looking to develop RNA/LNP capabilities.

Working with biologics and looking to enter the RNA space.

Aiming to boost your RNA therapeutics skills.

Our course availability

Secure your place on 'Introduction to RNA therapeutics'.

25 Oct 2022: 09:00am to 10:30am
Introduction to RNA therapeutics
Interactive
Register

22 Nov 2022: 15:00pm to 16:30pm
Introduction to RNA therapeutics
Interactive
Register

13 Dec 2022: 09:00am to 10:30am
Introduction to RNA therapeutics
Interactive
Register

08 Nov 2022: 15:00pm to 16:00pm
Introduction to RNA therapeutics
Recorded
Register

06 Dec 2022: 09:00am to 10:00am
Introduction to RNA therapeutics
Recorded
Register

15 Dec 2022: 15:00pm to 16:00pm
Introduction to RNA therapeutics
Recorded
Register

Any questions?

Find out more about 'Introduction to RNA therapeutics' and enquire about group bookings by connecting with a member of our RNA Training Academy team on the button below.

Get in touch

CPI’s RNA Centre of Excellence is the only UK-based centre currently able to develop and manufacture lipid nanoparticle encapsulated messenger and self-amplifying RNA vaccines and therapies ready for use in early-phase clinical trials. Read more about our RNA capabilities.

Privacy Policy | T&C | Cancellations